Cargando…
Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessment
INTRODUCTION: Recent studies have reported a high prevalence of obstructive sleep apnoea (OSA) among patients with diffuse parenchymal lung disease (DPLD), mainly idiopathic pulmonary fibrosis (IPF). Effective OSA treatment appears to have a positive impact on morbidity and mortality in these patien...
Autores principales: | Cardoso, Ana Verónica, Pereira, Nuno, Neves, Inês, Santos, Vanessa, Jesus, José Miguel, Melo, Natália, Mota, Patrícia Caetano, Morais, António, Drummond, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Society of Respiratory Therapists
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422053/ https://www.ncbi.nlm.nih.gov/pubmed/30996642 http://dx.doi.org/10.29390/cjrt-2018-005 |
Ejemplares similares
-
Prevalence and impact of comorbid obstructive sleep apnoea in diffuse parenchymal lung diseases
por: Li, Diandian, et al.
Publicado: (2021) -
Relationship between metabolic syndrome & obstructive sleep apnoea in a hospital-based urban population
por: Mota, Patrícia Caetano
Publicado: (2011) -
Are symptoms of obstructive sleep apnoea related to good continuous positive airway pressure compliance?
por: Kaewkes, Chaiwat, et al.
Publicado: (2020) -
O013 The pathogenesis of obstructive sleep apnea in individuals with comorbid insomnia and obstructive sleep apnoea (COMISA)
por: Brooker, E, et al.
Publicado: (2021) -
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea–COPD overlap syndrome: data from the European Sleep Apnoea Database
por: van Zeller, Mafalda, et al.
Publicado: (2023)